Anteris Technologies Global Corp. Common Stock (AVR) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Anteris Technologies Global Corp. Common Stock stock (AVR) is currently trading at $5.39. Anteris Technologies Global Corp. Common Stock PS ratio (Price-to-Sales) is 284.63. Analyst consensus price target for AVR is $15.75. WallStSmart rates AVR as Sell.
- AVR PE ratio analysis and historical PE chart
- AVR PS ratio (Price-to-Sales) history and trend
- AVR intrinsic value — DCF, Graham Number, EPV models
- AVR stock price prediction 2025 2026 2027 2028 2029 2030
- AVR fair value vs current price
- AVR insider transactions and insider buying
- Is AVR undervalued or overvalued?
- Anteris Technologies Global Corp. Common Stock financial analysis — revenue, earnings, cash flow
- AVR Piotroski F-Score and Altman Z-Score
- AVR analyst price target and Smart Rating
Anteris Technologies Global Corp.
📊 No data available
Try selecting a different time range
Smart Analysis
Anteris Technologies Global Corp. Common Stock (AVR) · 7 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Concerns around return on equity and operating margin. Significant fundamental concerns warrant caution or avoidance.
Anteris Technologies Global Corp. Common Stock (AVR) Key Strengths (0)
Supporting Valuation Data
Anteris Technologies Global Corp. Common Stock (AVR) Areas to Watch (7)
Company is destroying shareholder value
Losing money on operations
Revenue declining -42.20%, a shrinking business
Very expensive at 284.6x annual revenue
Very expensive at 165.9x book value
Small-cap company with higher risk but more growth potential
Moderate institutional interest at 33.18%
Supporting Valuation Data
Anteris Technologies Global Corp. Common Stock (AVR) Detailed Analysis Report
Overall Assessment
This company scores 13/100 in our Smart Analysis, earning a F grade. Out of 7 metrics analyzed, 0 register as strengths (avg 0/10) while 7 fall into concern territory (avg 2.1/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
Limited fundamental strengths were identified. The bull case requires improvement in core metrics.
The Bear Case
The primary concerns are Return on Equity, Operating Margin, Revenue Growth. Some valuation metrics including Price/Sales (284.63), Price/Book (165.91) suggest expensive pricing. Growth concerns include Revenue Growth at -42.20%, which may limit upside. Profitability pressure is visible in Return on Equity at -301.90%, Operating Margin at -9344.00%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -301.90% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -42.20% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
AVR Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
AVR's Price-to-Sales ratio of 284.63x sits near its historical average of 310.76x (0th percentile), suggesting the market is pricing in steady-state growth. The current valuation is 15% below its historical high of 335.15x set in Mar 2026, and 0% above its historical low of 284.63x in Mar 2026. Over the past 12 months, the PS ratio has compressed from ~321.0x as trailing revenue scaled faster than the stock price.
WallStSmart Analysis Synopsis
Data-driven financial summary for Anteris Technologies Global Corp. Common Stock (AVR) · HEALTHCARE › MEDICAL INSTRUMENTS & SUPPLIES
The Big Picture
Anteris Technologies Global Corp. Common Stock operates as a stable business with moderate growth and solid fundamentals. Revenue reached 2M with 42% decline year-over-year.
Key Findings
Spending 1020% of revenue (20M) on R&D, reinforcing its commitment to innovation and future growth.
Revenue contracted 42% YoY. Worth determining whether this is cyclical or structural.
Free cash flow is -19M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Sector dynamics: monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive moves, and regulatory changes that could impact Anteris Technologies Global Corp. Common Stock.
Bottom Line
Anteris Technologies Global Corp. Common Stock offers stability with moderate growth and solid fundamentals. The valuation may present an opportunity for patient investors, though limited growth means returns will likely come from dividends and modest capital appreciation rather than explosive gains.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Data sourced from SEC Form 4 filings
Last updated: 11:29:08 AM
About Anteris Technologies Global Corp. Common Stock(AVR)
NASDAQ
HEALTHCARE
MEDICAL INSTRUMENTS & SUPPLIES
USA
Anteris Technologies Global Corp. The company is headquartered in Toowong, Australia.